Global Thrombosis Drug Market Research Report 2024

Report ID: 1969720 | Published Date: Jan 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Thrombosis Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 P2Y12 Platelet Inhibitor
        1.2.3 Xa Inhibitor
        1.2.4 Heparin
    1.3 Market by Application
        1.3.1 Global Thrombosis Drug Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Deep Vein Thrombosis
        1.3.3 Pulmonary Embolism
        1.3.4 Atrial Fibrillation
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Thrombosis Drug Market Perspective (2017-2028)
    2.2 Thrombosis Drug Growth Trends by Region
        2.2.1 Thrombosis Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Thrombosis Drug Historic Market Size by Region (2017-2022)
        2.2.3 Thrombosis Drug Forecasted Market Size by Region (2023-2028)
    2.3 Thrombosis Drug Market Dynamics
        2.3.1 Thrombosis Drug Industry Trends
        2.3.2 Thrombosis Drug Market Drivers
        2.3.3 Thrombosis Drug Market Challenges
        2.3.4 Thrombosis Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Thrombosis Drug Players by Revenue
        3.1.1 Global Top Thrombosis Drug Players by Revenue (2017-2022)
        3.1.2 Global Thrombosis Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Thrombosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Thrombosis Drug Revenue
    3.4 Global Thrombosis Drug Market Concentration Ratio
        3.4.1 Global Thrombosis Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Thrombosis Drug Revenue in 2021
    3.5 Thrombosis Drug Key Players Head office and Area Served
    3.6 Key Players Thrombosis Drug Product Solution and Service
    3.7 Date of Enter into Thrombosis Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Thrombosis Drug Breakdown Data by Type
    4.1 Global Thrombosis Drug Historic Market Size by Type (2017-2022)
    4.2 Global Thrombosis Drug Forecasted Market Size by Type (2023-2028)
5 Thrombosis Drug Breakdown Data by Application
    5.1 Global Thrombosis Drug Historic Market Size by Application (2017-2022)
    5.2 Global Thrombosis Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Thrombosis Drug Market Size (2017-2028)
    6.2 North America Thrombosis Drug Market Size by Country (2017-2022)
    6.3 North America Thrombosis Drug Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Thrombosis Drug Market Size (2017-2028)
    7.2 Europe Thrombosis Drug Market Size by Country (2017-2022)
    7.3 Europe Thrombosis Drug Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Thrombosis Drug Market Size (2017-2028)
    8.2 Asia-Pacific Thrombosis Drug Market Size by Country (2017-2022)
    8.3 Asia-Pacific Thrombosis Drug Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Thrombosis Drug Market Size (2017-2028)
    9.2 Latin America Thrombosis Drug Market Size by Country (2017-2022)
    9.3 Latin America Thrombosis Drug Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Thrombosis Drug Market Size (2017-2028)
    10.2 Middle East & Africa Thrombosis Drug Market Size by Country (2017-2022)
    10.3 Middle East & Africa Thrombosis Drug Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Thrombosis Drug Introduction
        11.1.4 Pfizer Revenue in Thrombosis Drug Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Aspen Pharmacare Holdings Limited
        11.2.1 Aspen Pharmacare Holdings Limited Company Detail
        11.2.2 Aspen Pharmacare Holdings Limited Business Overview
        11.2.3 Aspen Pharmacare Holdings Limited Thrombosis Drug Introduction
        11.2.4 Aspen Pharmacare Holdings Limited Revenue in Thrombosis Drug Business (2017-2022)
        11.2.5 Aspen Pharmacare Holdings Limited Recent Development
    11.3 Bayer AG
        11.3.1 Bayer AG Company Detail
        11.3.2 Bayer AG Business Overview
        11.3.3 Bayer AG Thrombosis Drug Introduction
        11.3.4 Bayer AG Revenue in Thrombosis Drug Business (2017-2022)
        11.3.5 Bayer AG Recent Development
    11.4 AstraZeneca plc
        11.4.1 AstraZeneca plc Company Detail
        11.4.2 AstraZeneca plc Business Overview
        11.4.3 AstraZeneca plc Thrombosis Drug Introduction
        11.4.4 AstraZeneca plc Revenue in Thrombosis Drug Business (2017-2022)
        11.4.5 AstraZeneca plc Recent Development
    11.5 Sanofi
        11.5.1 Sanofi Company Detail
        11.5.2 Sanofi Business Overview
        11.5.3 Sanofi Thrombosis Drug Introduction
        11.5.4 Sanofi Revenue in Thrombosis Drug Business (2017-2022)
        11.5.5 Sanofi Recent Development
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Company Detail
        11.6.2 Johnson & Johnson Business Overview
        11.6.3 Johnson & Johnson Thrombosis Drug Introduction
        11.6.4 Johnson & Johnson Revenue in Thrombosis Drug Business (2017-2022)
        11.6.5 Johnson & Johnson Recent Development
    11.7 Bristol-Myers Squibb Company
        11.7.1 Bristol-Myers Squibb Company Company Detail
        11.7.2 Bristol-Myers Squibb Company Business Overview
        11.7.3 Bristol-Myers Squibb Company Thrombosis Drug Introduction
        11.7.4 Bristol-Myers Squibb Company Revenue in Thrombosis Drug Business (2017-2022)
        11.7.5 Bristol-Myers Squibb Company Recent Development
    11.8 Baxter International Inc.
        11.8.1 Baxter International Inc. Company Detail
        11.8.2 Baxter International Inc. Business Overview
        11.8.3 Baxter International Inc. Thrombosis Drug Introduction
        11.8.4 Baxter International Inc. Revenue in Thrombosis Drug Business (2017-2022)
        11.8.5 Baxter International Inc. Recent Development
    11.9 Boehringer Ingelheim GmbH
        11.9.1 Boehringer Ingelheim GmbH Company Detail
        11.9.2 Boehringer Ingelheim GmbH Business Overview
        11.9.3 Boehringer Ingelheim GmbH Thrombosis Drug Introduction
        11.9.4 Boehringer Ingelheim GmbH Revenue in Thrombosis Drug Business (2017-2022)
        11.9.5 Boehringer Ingelheim GmbH Recent Development
    11.10 GlaxoSmithKline plc.
        11.10.1 GlaxoSmithKline plc. Company Detail
        11.10.2 GlaxoSmithKline plc. Business Overview
        11.10.3 GlaxoSmithKline plc. Thrombosis Drug Introduction
        11.10.4 GlaxoSmithKline plc. Revenue in Thrombosis Drug Business (2017-2022)
        11.10.5 GlaxoSmithKline plc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Thrombosis Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of P2Y12 Platelet Inhibitor
    Table 3. Key Players of Xa Inhibitor
    Table 4. Key Players of Heparin
    Table 5. Global Thrombosis Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Thrombosis Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Thrombosis Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Thrombosis Drug Market Share by Region (2017-2022)
    Table 9. Global Thrombosis Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Thrombosis Drug Market Share by Region (2023-2028)
    Table 11. Thrombosis Drug Market Trends
    Table 12. Thrombosis Drug Market Drivers
    Table 13. Thrombosis Drug Market Challenges
    Table 14. Thrombosis Drug Market Restraints
    Table 15. Global Thrombosis Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Thrombosis Drug Market Share by Players (2017-2022)
    Table 17. Global Top Thrombosis Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombosis Drug as of 2021)
    Table 18. Ranking of Global Top Thrombosis Drug Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Thrombosis Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Thrombosis Drug Product Solution and Service
    Table 22. Date of Enter into Thrombosis Drug Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Thrombosis Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Thrombosis Drug Revenue Market Share by Type (2017-2022)
    Table 26. Global Thrombosis Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Thrombosis Drug Revenue Market Share by Type (2023-2028)
    Table 28. Global Thrombosis Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Thrombosis Drug Revenue Market Share by Application (2017-2022)
    Table 30. Global Thrombosis Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Thrombosis Drug Revenue Market Share by Application (2023-2028)
    Table 32. North America Thrombosis Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Thrombosis Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Thrombosis Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Thrombosis Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Thrombosis Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Thrombosis Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Thrombosis Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Thrombosis Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Thrombosis Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Thrombosis Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Pfizer Company Detail
    Table 43. Pfizer Business Overview
    Table 44. Pfizer Thrombosis Drug Product
    Table 45. Pfizer Revenue in Thrombosis Drug Business (2017-2022) & (US$ Million)
    Table 46. Pfizer Recent Development
    Table 47. Aspen Pharmacare Holdings Limited Company Detail
    Table 48. Aspen Pharmacare Holdings Limited Business Overview
    Table 49. Aspen Pharmacare Holdings Limited Thrombosis Drug Product
    Table 50. Aspen Pharmacare Holdings Limited Revenue in Thrombosis Drug Business (2017-2022) & (US$ Million)
    Table 51. Aspen Pharmacare Holdings Limited Recent Development
    Table 52. Bayer AG Company Detail
    Table 53. Bayer AG Business Overview
    Table 54. Bayer AG Thrombosis Drug Product
    Table 55. Bayer AG Revenue in Thrombosis Drug Business (2017-2022) & (US$ Million)
    Table 56. Bayer AG Recent Development
    Table 57. AstraZeneca plc Company Detail
    Table 58. AstraZeneca plc Business Overview
    Table 59. AstraZeneca plc Thrombosis Drug Product
    Table 60. AstraZeneca plc Revenue in Thrombosis Drug Business (2017-2022) & (US$ Million)
    Table 61. AstraZeneca plc Recent Development
    Table 62. Sanofi Company Detail
    Table 63. Sanofi Business Overview
    Table 64. Sanofi Thrombosis Drug Product
    Table 65. Sanofi Revenue in Thrombosis Drug Business (2017-2022) & (US$ Million)
    Table 66. Sanofi Recent Development
    Table 67. Johnson & Johnson Company Detail
    Table 68. Johnson & Johnson Business Overview
    Table 69. Johnson & Johnson Thrombosis Drug Product
    Table 70. Johnson & Johnson Revenue in Thrombosis Drug Business (2017-2022) & (US$ Million)
    Table 71. Johnson & Johnson Recent Development
    Table 72. Bristol-Myers Squibb Company Company Detail
    Table 73. Bristol-Myers Squibb Company Business Overview
    Table 74. Bristol-Myers Squibb Company Thrombosis Drug Product
    Table 75. Bristol-Myers Squibb Company Revenue in Thrombosis Drug Business (2017-2022) & (US$ Million)
    Table 76. Bristol-Myers Squibb Company Recent Development
    Table 77. Baxter International Inc. Company Detail
    Table 78. Baxter International Inc. Business Overview
    Table 79. Baxter International Inc. Thrombosis Drug Product
    Table 80. Baxter International Inc. Revenue in Thrombosis Drug Business (2017-2022) & (US$ Million)
    Table 81. Baxter International Inc. Recent Development
    Table 82. Boehringer Ingelheim GmbH Company Detail
    Table 83. Boehringer Ingelheim GmbH Business Overview
    Table 84. Boehringer Ingelheim GmbH Thrombosis Drug Product
    Table 85. Boehringer Ingelheim GmbH Revenue in Thrombosis Drug Business (2017-2022) & (US$ Million)
    Table 86. Boehringer Ingelheim GmbH Recent Development
    Table 87. GlaxoSmithKline plc. Company Detail
    Table 88. GlaxoSmithKline plc. Business Overview
    Table 89. GlaxoSmithKline plc. Thrombosis Drug Product
    Table 90. GlaxoSmithKline plc. Revenue in Thrombosis Drug Business (2017-2022) & (US$ Million)
    Table 91. GlaxoSmithKline plc. Recent Development
    Table 92. Research Programs/Design for This Report
    Table 93. Key Data Information from Secondary Sources
    Table 94. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Thrombosis Drug Market Share by Type: 2021 VS 2028
    Figure 2. P2Y12 Platelet Inhibitor Features
    Figure 3. Xa Inhibitor Features
    Figure 4. Heparin Features
    Figure 5. Global Thrombosis Drug Market Share by Application in 2021 & 2028
    Figure 6. Deep Vein Thrombosis Case Studies
    Figure 7. Pulmonary Embolism Case Studies
    Figure 8. Atrial Fibrillation Case Studies
    Figure 9. Thrombosis Drug Report Years Considered
    Figure 10. Global Thrombosis Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Thrombosis Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Thrombosis Drug Market Share by Region: 2021 VS 2028
    Figure 13. Global Thrombosis Drug Market Share by Players in 2021
    Figure 14. Global Top Thrombosis Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombosis Drug as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Thrombosis Drug Revenue in 2021
    Figure 16. North America Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Thrombosis Drug Market Share by Country (2017-2028)
    Figure 18. United States Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Thrombosis Drug Market Share by Country (2017-2028)
    Figure 22. Germany Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Thrombosis Drug Market Share by Region (2017-2028)
    Figure 30. China Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Thrombosis Drug Market Share by Country (2017-2028)
    Figure 38. Mexico Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Thrombosis Drug Market Share by Country (2017-2028)
    Figure 42. Turkey Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Thrombosis Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Pfizer Revenue Growth Rate in Thrombosis Drug Business (2017-2022)
    Figure 45. Aspen Pharmacare Holdings Limited Revenue Growth Rate in Thrombosis Drug Business (2017-2022)
    Figure 46. Bayer AG Revenue Growth Rate in Thrombosis Drug Business (2017-2022)
    Figure 47. AstraZeneca plc Revenue Growth Rate in Thrombosis Drug Business (2017-2022)
    Figure 48. Sanofi Revenue Growth Rate in Thrombosis Drug Business (2017-2022)
    Figure 49. Johnson & Johnson Revenue Growth Rate in Thrombosis Drug Business (2017-2022)
    Figure 50. Bristol-Myers Squibb Company Revenue Growth Rate in Thrombosis Drug Business (2017-2022)
    Figure 51. Baxter International Inc. Revenue Growth Rate in Thrombosis Drug Business (2017-2022)
    Figure 52. Boehringer Ingelheim GmbH Revenue Growth Rate in Thrombosis Drug Business (2017-2022)
    Figure 53. GlaxoSmithKline plc. Revenue Growth Rate in Thrombosis Drug Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Aspen Pharmacare Holdings Limited
Bayer AG
AstraZeneca plc
Sanofi
Johnson & Johnson
Bristol-Myers Squibb Company
Baxter International Inc.
Boehringer Ingelheim GmbH
GlaxoSmithKline plc.
Frequently Asked Questions
Thrombosis Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Thrombosis Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Thrombosis Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Liquid Makeup

Liquid Makeup market is segmented by players, region (country), by Type and by Channel. Players,  ... Read More

Carbomer Resin

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More